Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
Reset 

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2021 Release Date

STATESVILLE, N.C., Nov. 23, 2020 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its second quarter fiscal year 2021 financial results on Wednesday, December 9, 2020 after the close of trading. This information will be available... Read more ››

By: PR Newswire Association LLC. - 23 Nov 2020
Related companies:  Kewaunee Scientific Corporation

Mirati Therapeutics To Participate In The 2020 Evercore ISI HealthCONx Conference

SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced they will participate in a fireside chat at the 2020 Evercore ISI HealthCONx Conference on Tuesday, December 1(st) at 8:20 a.m. PT/11:20 a.m. ET. Dan... Read more ››

By: PR Newswire Association LLC. - 23 Nov 2020
Related companies:  Mirati Therapeutics, Inc.

Global Live Cell Imaging Market Report 2020-2025: Market Size is Projected to Reach USD 2.8 Billion by 2025 from USD 1.8 Billion in 2020

DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 23 Nov 2020

Psoriatic Arthritis Disease Overview, Epidemiology and Disease Management Forecasts

DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 23 Nov 2020

Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development

CARLSBAD, Calif., Nov. 23, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that the biopharmaceutical company AstraZeneca has licensed ION455, an investigational antisense medicine being developed as a potential treatment for nonalcoholic steatohepatitis (NASH).... Read more ››

By: PR Newswire Association LLC. - 23 Nov 2020
Related companies:  Ionis Pharmaceuticals, Inc.

Metacrine to Participate in Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Metacrine, Inc.

IGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  IGM Biosciences, Inc.

Cerevel Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Cerevel Therapeutics Holdings, Inc.

Aquestive Therapeutics Receives First Milestone Payment from KYNMOBI™ Monetization

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Aquestive Therapeutics, Inc.

VitalHub Selected to Present at the Canaccord Genuity Virtual Health and Wellness Conference

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  VitalHub Corporation

Myovant Sciences to Present at Upcoming December Investor Conferences

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Myovant Sciences, Inc.

Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Summit Therapeutics plc

Amicus Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Amicus Therapeutics, Inc.

Oxford Biomedica notes AstraZeneca’s AZD1222 met primary efficacy endpoint in preventing COVID-19

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Oxford BioMedica plc

Oxford Biomedica Appoints Dr. Sam Rasty as Non-Executive Director

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Oxford BioMedica plc

Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical Development

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Medicure Inc.

Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Algernon Pharmaceuticals Inc.

Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Cytokinetics, Inc.

Arcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp and Body Psoriasis

Read more ››
By: GlobenewsWire - 23 Nov 2020
Related companies:  Arcutis Biotherapeutics, Inc.

Medicenna to Participate in Upcoming December Investor Conferences

Read more ››
By: GlobenewsWire - 23 Nov 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
to the top ↑